ROIV Roivant Sciences Ltd. - Common Shares
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 6, 2026
$35,72
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$15,2552 haftanın en düşüğü
$42,5052 haftanın en yükseği
Piyasa Değeri (MRQ)
$25.81B
P/E (TTM)
-76.0
Hisse Başına Kâr (TTM)
$-0.47
Gelir (TTM)
$8M
rozetleriniz
52 Haftlık Aralık
$15–$42
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$48
P/E
-76.0
ROE
-6.2%
Net Kâr Marjı
-3535.0%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
ROIV Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$35.72
Piyasa Değeri (MRQ)
$25.81B
P/E (TTM)
-76.0
Hisse Başına Kâr (TTM)
$-0.47
Gelir (TTM)
$8M
ROE (TTM)
-6.2%
52 Haftlık Aralık
$15–$43
ROIV Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$8M2021-03-31 → 2026-03-31
Hisse Başına Kâr$-0.542022-03-31 → 2026-03-31
Serbest Nakit Akışı$-759M2022-03-31 → 2026-03-31
Net kar marjı-3535.0%2022-03-31 → 2026-03-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | ROIV | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -76.05Y ort. ≈-20.1 | ≈-20.1 | · | · | |
| F/S (TTM) | 3427.25Y ort. ≈631.5 | ≈631.5 | · | · | |
| F/D (MRQ) | 6.15Y ort. ≈2.8 | ≈2.8 | 6.8 | Adil değer | |
| Fiyat / Serbest Nakit Akışı (TTM) | -31.45Y ort. ≈-11.4 | ≈-11.4 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -31.65Y ort. ≈-11.6 | ≈-11.6 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 5.75Y ort. ≈3.0 | ≈3.0 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | ROIV | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | -7914.8%5Y ort. ≈-2130.5% | ≈-2130.5% | -49.3% | Zayıf | |
| FAVÖK Marjı (TTM) | -7876.9%5Y ort. ≈-2103.0% | ≈-2103.0% | -49.3% | Zayıf | |
| Vergi Öncesi Kar Marjı (TTM) | -3848.6%5Y ort. ≈-1162.1% | ≈-1162.1% | -42.5% | Zayıf | |
| Net Kâr Marjı (TTM) | -3535.0%5Y ort. ≈-782.4% | ≈-782.4% | -43.1% | Zayıf | |
| ROA (TTM) | -5.2%5Y ort. ≈1.8% | ≈1.8% | -5.4% | Aynı seviyede | |
| ROE (TTM) | -6.2%5Y ort. ≈-1.7% | ≈-1.7% | -9.2% | En üst düzey | |
| ROIC | -17.1%5Y ort. ≈-28.1% | ≈-28.1% | -17.1% | Aynı seviyede |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | ROIV | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 16.75Y ort. ≈19.1 | ≈19.1 | 4.5 | Güçlü likidite | |
| Quick Ratio (Cari Oran) | 15.35Y ort. ≈18.0 | ≈18.0 | 3.2 | Güçlü likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | ROIV | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | -71.6%5Y ort. ≈2.1% | ≈2.1% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | -36.0%5Y ort. ≈-14.7% | ≈-14.7% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | -19.1% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | ROIV | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.05Y ort. ≈0.0 | ≈0.0 | 0.2 | Zayıf | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$11.5K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Kazanma Oranı
62.5%
Ort. Sürpriz
3.2%
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 31 Mart 2027 | $-0.26 | $-0.34 | 22.6% | |
| 31 Aralık 2026 | May 20, 2026 | $-0.58 | $-0.35 | -64.6% |
| 30 Haziran 2026 | $-0.26 | $-0.34 | 22.6% | |
| 31 Mart 2026 | $-0.32 | $-0.35 | 9.2% | |
| 31 Aralık 2025 | $-0.38 | $-0.32 | -17.3% | |
| 30 Eylül 2025 | $-0.17 | $-0.34 | 50.1% | |
| 30 Haziran 2025 | $-0.33 | $-0.32 | -4.4% | |
| 31 Mart 2025 | $-0.29 | $-0.31 | 7.7% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| Revenue | $8M | $29M | $33M | $32M | $55M | $24M | |
| R&D Expense | $682M | $550M | $440M | $454M | $483M | $237M | |
| SG&A Expense | $610M | $591M | $416M | $383M | $775M | $260M | |
| Operating Expenses | $1.29B | $1.14B | $884M | $938M | $1.41B | $1.09B | |
| Operating Income | $-515M | $-1.00B | $4.50B | $-907M | $-1.35B | $-1.07B | |
| Interest Expense | · | · | $35M | $28M | $7M | $3M | |
| Interest Income | $178M | $258M | $146M | · | · | · | |
| Other Non-op | $4M | $-11M | $-14M | $-486.0K | $3M | $-9M | |
| Pretax Income | $-265M | $-682M | $4.57B | $-885M | $-924M | $-899M | |
| Income Tax | $133M | $48M | $22M | $4M | $369.0K | $2M | |
| Net Income | $-300M | $-172M | $4.35B | $-1.01B | $-845M | $-809M | |
| EPS (Basic) | $-0.43 | $-0.24 | $5.55 | $-1.42 | $-1.26 | · | |
| EPS (Diluted) | $-0.54 | $-0.24 | $5.23 | $-1.42 | $-1.26 | · | |
| Shares (Basic) | 693,864,530 | 725,395,624 | 783,248,906 | 712,791,115 | 669,753,458 | · | |
| Shares (Diluted) | 693,864,530 | 725,395,624 | 831,049,444 | 712,791,115 | 669,753,458 | · | |
| EBITDA | $-512M | $-989M | $4.26B | $-1.16B | $-1.35B | · |
Bilanço
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.42B | $2.72B | $6.49B | $1.68B | $2.06B | $2.06B | |
| Short-term Investments | $2.87B | $2.17B | $0 | · | · | · | |
| Receivables | · | · | $4M | $30M | $4M | $11M | |
| Inventory | · | · | $35M | $3M | $0 | · | |
| Prepaid Expense | · | · | $34M | $61M | $53M | $40M | |
| Other Current Assets | $105M | $113M | $81M | $122M | $86M | $54M | |
| Current Assets | $5.17B | $5.00B | $6.73B | $1.80B | $2.15B | $2.19B | |
| PP&E (Net) | $12M | $12M | $15M | $39M | $26M | $15M | |
| Intangibles | · | · | $138M | $145M | $0 | · | |
| Other Non-current Assets | $41M | $33M | $38M | $49M | $26M | $27M | |
| Total Assets | $5.71B | $5.44B | $7.22B | $2.39B | $2.59B | $2.59B | |
| Accounts Payable | $18M | $24M | $14M | $38M | $35M | $21M | |
| Accrued Liabilities | $206M | $114M | $119M | $167M | $128M | $77M | |
| Short-term Debt | · | · | · | · | $0 | · | |
| Current Liabilities | $281M | $149M | $267M | $272M | $184M | $219M | |
| Capital Leases | $96M | $90M | $45M | $53M | $62M | $62M | |
| Other Non-current Liabilities | $70.0K | $22.0K | $2M | $17M | $22M | $8M | |
| Total Liabilities | $416M | $250M | $774M | $782M | $524M | $528M | |
| Long-term Debt | · | · | $431M | $376M | $210M | $170M | |
| Total Debt | · | · | $12M | $41M | $210M | · | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | |
| Paid-in Capital | $5.02B | $4.56B | $5.40B | $4.93B | $4.42B | $3.81B | |
| Retained Earnings | $-502M | $116M | $576M | $-3.77B | $-2.76B | $-1.92B | |
| AOCI | $4M | $9M | $-4M | $-3M | $-946.0K | $1M | |
| Stockholders' Equity | $4.53B | $4.69B | $5.97B | $1.16B | $1.66B | $1.80B | |
| Liabilities + Equity | $5.71B | $5.44B | $7.22B | $2.39B | $2.59B | $2.59B | |
| Shares Outstanding | 720,352,386 | 695,938,323 | 806,677,954 | 760,143,393 | 694,975,965 | 651,576,293 |
Nakit Akışı
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| D&A | $3M | $14M | $22M | $19M | $6M | · | |
| Stock-based Comp | $346M | $289M | $200M | $218M | $565M | $85M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Other Non-cash | $-800M | $-971M | $-5.34B | $-71M | · | · | |
| Operating Cash Flow | $-750M | $-839M | $-765M | $-843M | $-678M | $-552M | |
| CapEx | $8M | $5M | $1M | $13M | $17M | $6M | |
| Investing Cash Flow | $-682M | $-1.77B | $5.20B | $-44M | $303M | $-32M | |
| Stock Issued | $0 | $0 | $200M | $312M | $0 | · | |
| Stock Repurchased | · | $1.29B | $0 | $0 | · | · | |
| Net Stock Activity | $0 | $-1.29B | $200M | $312M | · | · | |
| Financing Cash Flow | $134M | $-1.22B | $419M | $499M | $307M | $456M | |
| Net Change in Cash | $-1.29B | $-3.82B | $4.86B | $-382M | $-68M | · | |
| Taxes Paid | $48M | $62M | $12M | $5M | $916.0K | $4M | |
| Free Cash Flow | $-759M | $-844M | $-767M | $-856M | $-695M | · | |
| Levered FCF | · | · | $-801M | $-884M | $-702M | · |
Kârlılık
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -6235.7% | -3453.3% | 3399.2% | -1918.0% | -2444.8% | · | |
| Net Margin | -3629.2% | -592.0% | 3484.9% | -1646.6% | -1528.9% | · | |
| Pretax Margin | -3203.1% | -2346.0% | 3408.3% | -1998.8% | -1670.9% | · | |
| EBITDA Margin | -6195.2% | -3404.9% | 3416.9% | -1887.2% | -2444.8% | · | |
| ROA | -5.4% | -2.7% | 90.5% | -40.6% | -32.7% | · | |
| ROE | -6.5% | -3.2% | 122.0% | -71.7% | -48.9% | · | |
| ROIC | -17.1% | -22.9% | 70.6% | -98.5% | -72.4% | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 18.4 | 33.5 | 25.2 | 6.6 | 11.6 | · | |
| Quick Ratio | 15.3 | 32.7 | 24.7 | 6.3 | 11.2 | · | |
| Debt / Equity | · | · | 0.0 | 0.0 | 0.1 | · | |
| LT Debt / Equity | · | · | · | · | 0.1 | · | |
| Interest Coverage | · | · | 122.0 | -42.0 | -192.0 | · |
Verimlilik
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | |
| Receivables Turnover | · | · | 3.0 | 3.6 | · | · |
Hisse Başına
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.28 | $6.74 | $7.40 | $1.52 | $2.38 | · | |
| Revenue / Share | $0.01 | $0.04 | $0.15 | $0.09 | · | · | |
| Cash Flow / Share | $-1.08 | $-1.16 | $-0.92 | $-1.18 | · | · | |
| Cash / Share | $1.97 | $3.90 | $8.10 | $2.21 | $2.96 | · | |
| EPS (TTM) | $-0.54 | $-0.24 | $5.23 | $-1.42 | $-1.26 | · |
Büyüme Oranları
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -71.6% | -11.2% | 3.8% | -43.0% | 132.3% | · | |
| Revenue CAGR 3Y | -36.0% | -19.3% | 11.2% | · | · | · | |
| Revenue CAGR 5Y | -19.1% | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $29M | $33M | $32M | $55M | · | |
| Net Income TTM | $-300M | $-172M | $4.35B | $-1.01B | $-845M | · | |
| Market Cap | $19.95B | $7.02B | $8.50B | $5.61B | $3.43B | · | |
| Enterprise Value | · | · | $1.98B | $3.97B | $1.58B | · | |
| P/E | -51.3 | -42.0 | 2.0 | -5.2 | -3.9 | · | |
| P/S | 2415.7 | 241.7 | 259.9 | 177.9 | 62.1 | · | |
| P/B | 4.4 | 1.5 | 1.4 | 4.8 | 2.1 | · | |
| P / Tangible Book | 4.4 | 1.5 | 1.5 | 5.5 | 2.1 | · | |
| P / Cash Flow | -26.6 | -8.4 | -11.1 | -6.7 | -5.1 | · | |
| P / FCF | -26.3 | -8.3 | -11.1 | -6.6 | -4.9 | · | |
| EV / EBITDA | · | · | 0.5 | -3.4 | -1.2 | · | |
| EV / FCF | · | · | -2.6 | -4.6 | -2.3 | · | |
| EV / Revenue | · | · | 60.5 | 126.0 | 28.6 | · | |
| Earnings Yield | -1.9% | -2.4% | 49.6% | -19.2% | -25.5% | · |
Gelir Tablosu
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $3M | $2M | $2M | $2M | $8M | $9M | $4M | $8M | $-8M | $16M | $4M | $22M | $-2M | $17M | $13M | |
| R&D Expense | $202M | $199M | $165M | $165M | $153M | $145M | $142M | $143M | $121M | $92M | $108M | $115M | $125M | $61M | $126M | $132M | |
| SG&A Expense | $166M | $158M | $175M | $143M | $134M | $147M | $142M | $203M | $100M | $43M | $128M | $89M | $156M | $-92M | $168M | $158M | |
| Operating Expenses | $368M | $358M | $341M | $308M | $287M | $293M | $283M | $346M | $221M | $132M | $237M | $218M | $298M | $-37M | $395M | $293M | |
| Operating Income | $-366M | $415M | $-339M | $-306M | $-285M | $-285M | $-274M | $-342M | $-102M | $-140M | $5.13B | $-214M | $-276M | $34M | $-378M | $-281M | |
| Interest Expense | · | · | · | · | · | · | · | · | $13M | · | $9M | $9M | $9M | · | $8M | $8M | |
| Interest Income | $37M | $41M | $43M | $45M | $48M | $55M | $62M | $70M | · | · | · | · | · | · | · | · | |
| Other Non-op | $-2M | $13M | $8M | $-6M | $-11M | $-3M | $-3M | $-1M | $-4M | $-19M | $2M | $-2M | $5M | $-12M | $18M | $-6M | |
| Pretax Income | $-295M | $454M | $-290M | $-159M | $-269M | $-203M | $-235M | $-224M | $-20M | $-18M | $5.15B | $-241M | $-326M | $161M | $-382M | $-314M | |
| Income Tax | $-4M | $98M | $23M | $7M | $5M | $49M | $-26M | $12M | $12M | $-6M | $22M | $3M | $2M | $-5M | $3M | $2M | |
| Net Income | $-190M | $303M | $-266M | $-114M | $-223M | $-206M | $169M | $-230M | $95M | $-151M | $5.10B | $-304M | $-292M | $-34M | $-352M | $-292M | |
| EPS (Basic) | $-0.26 | $0.45 | $-0.38 | $-0.17 | $-0.33 | $-0.29 | $0.23 | $-0.31 | $0.13 | $-0.04 | $6.37 | $-0.40 | $-0.38 | $-0.03 | $-0.49 | $-0.42 | |
| EPS (Diluted) | $-0.26 | $0.34 | $-0.38 | $-0.17 | $-0.33 | $-0.28 | $0.23 | $-0.31 | $0.12 | $-0.02 | $6.03 | $-0.40 | $-0.38 | $-0.03 | $-0.49 | $-0.42 | |
| Shares (Basic) | 720,776,739 | · | 696,859,682 | 680,947,866 | 680,286,922 | · | 722,716,168 | 735,470,796 | 735,816,536 | · | 800,587,716 | 770,227,849 | 759,273,550 | · | 713,319,399 | 699,888,061 | |
| Shares (Diluted) | 720,776,739 | · | 696,859,682 | 680,947,866 | 680,286,922 | · | 722,716,168 | 735,470,796 | 781,627,601 | · | 844,461,685 | 770,227,849 | 759,273,550 | · | 713,319,399 | 699,888,061 | |
| EBITDA | $-365M | · | $-339M | $-306M | $-284M | · | $-274M | $-342M | $-115M | · | $5.06B | $-276M | $-271M | · | $-378M | $-281M |
Bilanço
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.25B | $1.42B | $1.48B | $1.24B | $1.24B | $2.72B | $1.99B | $1.96B | $5.68B | $6.49B | $6.67B | $1.41B | $1.43B | · | $1.53B | $1.60B | |
| Short-term Investments | $2.59B | $2.87B | $3.05B | $3.15B | $3.26B | $2.17B | $3.16B | $3.43B | · | $0 | · | · | · | · | · | · | |
| Receivables | · | · | · | · | · | · | $678.0K | $2M | $80M | · | $41M | $52M | $37M | · | $28M | $25M | |
| Inventory | · | · | · | · | · | · | · | · | $34M | · | $5M | $5M | $4M | · | · | · | |
| Prepaid Expense | · | · | · | · | · | · | $58M | $55M | $57M | · | $53M | $61M | $65M | · | $70M | $70M | |
| Other Current Assets | $128M | $105M | $130M | $126M | $113M | $113M | $217M | $94M | $323M | $81M | $136M | $143M | $127M | · | $119M | $112M | |
| Current Assets | $4.74B | $5.17B | $4.66B | $4.51B | $4.62B | $5.00B | $5.36B | $5.80B | $6.00B | $6.73B | $6.81B | $1.55B | $1.56B | · | $1.65B | $1.71B | |
| PP&E (Net) | $11M | $12M | $13M | $26M | $15M | $12M | $14M | $14M | $18M | $15M | $22M | $24M | $36M | · | $37M | $39M | |
| Intangibles | · | · | · | · | · | · | · | · | $136M | · | $150M | $141M | $145M | · | $146M | $140M | |
| Other Non-current Assets | $30M | $41M | $35M | $28M | $31M | $33M | $34M | $37M | $33M | $38M | $47M | $50M | $46M | · | $46M | $12M | |
| Total Assets | $5.31B | $5.71B | $5.23B | $5.06B | $5.03B | $5.44B | $5.79B | $6.21B | $6.50B | $7.22B | $7.31B | $2.07B | $2.14B | · | $2.20B | $2.22B | |
| Accounts Payable | $25M | $18M | $13M | $15M | $12M | $24M | $24M | $25M | $28M | $14M | $35M | $44M | $50M | · | $48M | $41M | |
| Accrued Liabilities | $169M | $206M | $118M | $108M | $89M | $114M | $104M | $111M | $138M | $119M | $122M | $153M | $119M | · | $132M | $129M | |
| Current Liabilities | $284M | $281M | $152M | $134M | $114M | $149M | $141M | $556M | $215M | $267M | $245M | $266M | $245M | · | $244M | $231M | |
| Capital Leases | $95M | $96M | $99M | $90M | $90M | $90M | $90M | $43M | $46M | $45M | $47M | $49M | $52M | · | $55M | $54M | |
| Other Non-current Liabilities | $6M | $70.0K | $677.0K | $170.0K | $228.0K | $22.0K | $307.0K | $295.0K | $2M | $2M | $4M | $5M | $17M | · | $21M | $9M | |
| Total Liabilities | $385M | $416M | $251M | $257M | $217M | $250M | $256M | $626M | $601M | $774M | $728M | $740M | $803M | · | $776M | $701M | |
| Long-term Debt | · | · | · | · | · | · | · | · | $312M | · | $403M | $389M | $385M | · | $375M | $376M | |
| Total Debt | · | · | · | · | · | · | · | · | $12M | · | $46M | $49M | $44M | · | $38M | $36M | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | |
| Paid-in Capital | $5.13B | $5.02B | $4.94B | $4.77B | $4.64B | $4.56B | $4.72B | $4.78B | $4.78B | $5.40B | $5.39B | $5.32B | $4.98B | · | $4.70B | $4.54B | |
| Retained Earnings | $-900M | $-502M | $-695M | $-429M | $-316M | $116M | $460M | $396M | $671M | $576M | $727M | $-4.37B | $-4.06B | · | $-3.74B | $-3.39B | |
| AOCI | $701.0K | $4M | $21M | $20M | $17M | $9M | $8M | $-18M | $-18M | $-4M | $-28M | $-3M | $-7M | · | $-729.0K | $9M | |
| Stockholders' Equity | $4.23B | $4.53B | $4.27B | $4.36B | $4.35B | $4.69B | $5.19B | $5.15B | $5.44B | $5.97B | $6.09B | $949M | $911M | · | $956M | $1.16B | |
| Liabilities + Equity | $5.31B | $5.71B | $5.23B | $5.06B | $5.03B | $5.44B | $5.79B | $6.21B | $6.50B | $7.22B | $7.31B | $2.07B | $2.14B | · | $2.20B | $2.22B | |
| Shares Outstanding | 722,668,062 | 720,352,386 | 709,689,411 | 689,697,370 | 682,229,832 | 695,938,323 | 719,632,367 | 733,328,375 | 739,053,106 | 806,677,954 | 804,890,910 | 800,792,365 | 767,137,861 | · | 726,804,831 | 704,386,981 |
Nakit Akışı
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $600.0K | $638.0K | $691.0K | $921.0K | $1M | $1M | $3M | $5M | $5M | $5M | $5M | $6M | $6M | $6M | $5M | $5M | |
| Stock-based Comp | $83M | $77M | $105M | $82M | $82M | $83M | $84M | $72M | $50M | $47M | $54M | $49M | $49M | $25M | $58M | $62M | |
| Other Non-cash | $-165M | · | · | · | $-64M | · | · | · | $-343M | · | · | · | $-13M | · | · | · | |
| Operating Cash Flow | $-271M | $-164M | $-196M | $-186M | $-204M | $-173M | $-207M | $-267M | $-193M | $-108M | $-210M | $-196M | $-250M | $-179M | $-223M | $-190M | |
| CapEx | $419.0K | $1M | $-5M | $8M | $4M | $811.0K | $2M | $996.0K | $965.0K | $349.0K | $355.0K | $275.0K | $403.0K | $2M | $508.0K | $3M | |
| Investing Cash Flow | $281M | $173M | $109M | $120M | $-1.09B | $1.07B | $454M | $-3.29B | $-965.0K | $7M | $5.23B | $-36M | $105.0K | $114M | $-4M | $-147M | |
| Stock Issued | · | · | · | · | · | $0 | $0 | · | · | $0 | $0 | · | · | $217M | $95M | · | |
| Stock Repurchased | $207M | · | $0 | $0 | $208M | $295M | $243M | $106M | $648M | $0 | $0 | $0 | $0 | · | · | · | |
| Net Stock Activity | $-207M | · | · | · | $-208M | · | · | · | $-648M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-182M | $-69M | $328M | $63M | $-188M | $-177M | $-273M | $-109M | $-661M | $-33M | $237M | $208M | $7M | $210M | $154M | $-7M | |
| Net Change in Cash | $-170M | $-58M | $242M | $-1M | $-1.48B | $724M | $-27M | $-3.66B | $-857M | $-135M | $5.26B | $-26M | $-242M | $151M | $-72M | $-344M | |
| Free Cash Flow | $-271M | · | · | · | $-208M | · | · | · | $-194M | · | · | · | $-250M | · | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | $-205M | · | · | · | $-259M | · | · | · |
Kârlılık
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -25380.9% | · | -16966.1% | -19492.9% | -13130.0% | · | -3042.6% | -7636.0% | -218.0% | · | 13626.5% | -745.1% | -1278.3% | · | -2217.2% | -2240.2% | |
| Net Margin | -13164.8% | · | -13301.2% | -7225.9% | -10292.9% | · | 1878.2% | -5143.8% | 172.8% | · | 13721.5% | -820.3% | -1349.5% | · | -2064.4% | -2326.6% | |
| Pretax Margin | -20427.5% | · | -14525.7% | -10123.7% | -12408.4% | · | -2600.5% | -5014.1% | 127.2% | · | 13727.4% | -882.3% | -1508.0% | · | -2240.7% | -2503.4% | |
| EBITDA Margin | -25339.3% | · | -16966.1% | -19492.9% | -13079.5% | · | -3042.6% | -7636.0% | -209.1% | · | 13626.5% | -745.1% | -1251.3% | · | -2217.2% | -2240.2% | |
| ROA | -3.7% | · | -4.8% | -2.0% | -3.9% | · | 2.6% | -5.6% | 2.2% | · | 107.1% | -14.2% | -12.3% | · | -14.1% | -11.0% | |
| ROE | -4.4% | · | -5.6% | -2.4% | -4.6% | · | 3.0% | -7.5% | 3.0% | · | 144.7% | -28.9% | -25.4% | · | -24.9% | -18.2% | |
| ROIC | -8.5% | · | -8.6% | -7.3% | -6.7% | · | -4.7% | -7.0% | -1.8% | · | 82.1% | -28.0% | -29.1% | · | -38.4% | -23.6% |
Likidite ve Solventlik
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 16.7 | · | 30.7 | 33.7 | 40.5 | · | 37.9 | 10.4 | 27.9 | · | 27.8 | 5.8 | 6.4 | · | 6.7 | 7.4 | |
| Quick Ratio | 13.5 | · | 29.8 | 32.8 | 39.5 | · | 36.4 | 9.7 | 26.8 | · | 27.4 | 5.5 | 6.0 | · | 6.4 | 7.0 | |
| Debt / Equity | · | · | · | · | · | · | · | · | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.0 | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -9.0 | · | 535.9 | -29.9 | -31.0 | · | · | · |
Verimlilik
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | 0.4 | 0.2 | 0.9 | · | 1.1 | 1.0 | 1.1 | · | 0.9 | 0.7 |
Hisse Başına
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.86 | · | $6.02 | $6.33 | $6.37 | · | $7.21 | $7.03 | $7.35 | · | $7.57 | $1.18 | $1.19 | · | $1.31 | $1.65 | |
| Revenue / Share | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.01 | $0.01 | $0.07 | · | $0.04 | $0.05 | $0.03 | · | $0.02 | $0.02 | |
| Cash Flow / Share | $-0.38 | · | · | · | $-0.30 | · | · | · | $-0.25 | · | · | · | $-0.33 | · | · | · | |
| Cash / Share | $1.73 | · | $2.08 | $1.79 | $1.82 | · | $2.77 | $2.67 | $7.68 | · | $8.29 | $1.76 | $1.87 | · | $2.10 | $2.27 | |
| EPS (TTM) | $-0.47 | · | $-1.16 | $-0.55 | $-0.69 | · | $0.02 | $5.82 | $5.73 | · | $5.22 | $-1.30 | $-1.32 | · | $-1.79 | $-1.71 |
Değerleme (TTM)
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | · | $13M | $20M | $23M | · | $13M | $20M | $19M | · | $38M | $40M | $49M | · | $43M | $50M | |
| Net Income TTM | $-266M | · | $-809M | $-374M | $-491M | · | $-117M | $4.81B | $4.74B | · | $4.47B | $-982M | $-969M | · | $-1.25B | $-1.18B | |
| Market Cap | $25.58B | · | $15.40B | $10.44B | $7.69B | · | $8.51B | $8.46B | $7.81B | · | $9.04B | $9.35B | $7.73B | · | $5.81B | $2.27B | |
| Enterprise Value | · | · | · | · | · | · | · | · | $2.15B | · | $2.41B | $7.99B | $6.34B | · | $4.32B | $705M | |
| P/E | -75.3 | · | -18.7 | -27.5 | -16.3 | · | 591.5 | 2.0 | 1.8 | · | 2.2 | -9.0 | -7.6 | · | -4.5 | -1.9 | |
| P/S | 3395.5 | · | 1157.0 | 513.3 | 330.9 | · | 637.1 | 425.1 | 409.4 | · | 235.0 | 234.1 | 158.3 | · | 134.7 | 45.0 | |
| P/B | 6.0 | · | 3.6 | 2.4 | 1.8 | · | 1.6 | 1.6 | 1.4 | · | 1.5 | 9.9 | 8.5 | · | 6.1 | 2.0 | |
| P / Tangible Book | 6.0 | · | 3.6 | 2.4 | 1.8 | · | 1.6 | 1.6 | 1.5 | · | 1.5 | 11.6 | 10.1 | · | 7.2 | 2.2 | |
| P / Cash Flow | -94.5 | · | · | · | -37.6 | · | · | · | -40.5 | · | · | · | -30.9 | · | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | 112.4 | · | 62.8 | 200.1 | 129.9 | · | 100.1 | 14.0 | |
| Earnings Yield | -1.3% | · | -5.3% | -3.6% | -6.1% | · | 0.17% | 50.4% | 54.2% | · | 46.5% | -11.1% | -13.1% | · | -22.4% | -53.1% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Gelir | $8M | $29M | $33M | $32M | $55M |
| Faaliyet Kâr Marjı % | -6235.7% | -3453.3% | 3399.2% | -1918.0% | -2444.8% |
| Net Gelir | $-300M | $-172M | $4.35B | $-1.01B | $-845M |
| Seyreltilmiş Hisse Başı Kâr | $-0.54 | $-0.24 | $5.23 | $-1.42 | $-1.26 |
| Metrik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | · | · | 0.0 | 0.0 | 0.1 |
| Cari Oran | 18.4 | 33.5 | 25.2 | 6.6 | 11.6 |
| Cari Oran | 15.3 | 32.7 | 24.7 | 6.3 | 11.2 |
| Metrik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-759M | $-844M | $-767M | $-856M | $-695M |
Kurumsal Sahipler (13F) 532 dosya · $21.1B toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
532
Tutulan Değer
$21.1B
Yeni pozisyonlar
104
Çıkan pozisyonlar
41
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 104 (+2 önceki Ç'ye göre) | 41 (-3 önceki Ç'ye göre) | 199 (+30 önceki Ç'ye göre) | 145 (+9 önceki Ç'ye göre) | +57.7M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| FMR LLC | $2.867.311.587 | 81.020.390 | 13,56% | Hisse senetleri |
| BlackRock, Inc. | $1.707.075.250 | 48.236.091 | 8,07% | Hisse senetleri |
| MORGAN STANLEY | $1.507.362.964 | 42.592.905 | 7,13% | Hisse senetleri |
| VANGUARD GROUP INC | $912.681.190 | 42.059.041 | 4,32% | Hisse senetleri |
| QVT Financial LP | $839.559.589 | 23.723.074 | 3,97% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $782.939.977 | 22.123.198 | 3,70% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $765.886.987 | 21.641.339 | 3,62% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $656.713.035 | 18.556.458 | 3,11% | Hisse senetleri |
| STATE STREET CORP | $629.799.555 | 17.795.975 | 2,98% | Hisse senetleri |
| UBS Group AG | $618.144.425 | 17.466.641 | 2,92% | Hisse senetleri |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $506.395.510 | 14.309.000 | 2,39% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $425.535.991 | 11.674.380 | 2,01% | Hisse senetleri |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $366.262.718 | 10.349.328 | 1,73% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $339.744.000 | 9.600.000 | 1,61% | Satım opsiyonu |
| Two Seas Capital LP | $299.942.849 | 8.475.356 | 1,42% | Hisse senetleri |
| Assenagon Asset Management S.A. | $295.964.871 | 8.362.952 | 1,40% | Hisse senetleri |
| PERCEPTIVE ADVISORS LLC | $286.144.465 | 8.085.461 | 1,35% | Hisse senetleri |
| Patient Square Capital LP | $283.860.642 | 8.020.928 | 1,34% | Hisse senetleri |
| Invesco Ltd. | $266.528.885 | 7.531.192 | 1,26% | Hisse senetleri |
| JANE STREET GROUP, LLC | $257.830.306 | 7.285.400 | 1,22% | Alım opsiyonu |
| Darwin Global Management, Ltd. | $234.333.729 | 6.747.300 | 1,11% | Hisse senetleri |
| AQR CAPITAL MANAGEMENT LLC | $234.031.996 | 6.633.560 | 1,11% | Hisse senetleri |
| VIKING GLOBAL INVESTORS LP | $221.947.217 | 6.271.467 | 1,05% | Hisse senetleri |
| Rubric Capital Management LP | $212.340.000 | 6.000.000 | 1,00% | Hisse senetleri |
| CITADEL ADVISORS LLC | $197.343.877 | 5.576.261 | 0,93% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $185.062.802 | 5.230.417 | 0,88% | Hisse senetleri |
| NORGES BANK | $168.013.034 | 4.747.472 | 0,79% | Hisse senetleri |
| BAKER BROS. ADVISORS LP | $166.928.649 | 4.716.831 | 0,79% | Hisse senetleri |
| JENNISON ASSOCIATES LLC | $158.616.723 | 4.481.964 | 0,75% | Hisse senetleri |
| Point72 Asset Management, L.P. | $158.316.386 | 4.473.478 | 0,75% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $153.641.473 | 4.341.381 | 0,73% | Hisse senetleri |
| NORTHERN TRUST CORP | $133.142.736 | 3.762.157 | 0,63% | Hisse senetleri |
| Affinity Asset Advisors, LLC | $132.712.500 | 3.750.000 | 0,63% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $131.494.872 | 3.715.594 | 0,62% | Hisse senetleri |
| Pictet Asset Management Holding SA | $122.694.773 | 3.468.340 | 0,58% | Hisse senetleri |
| Qube Research & Technologies Ltd | $122.254.613 | 3.454.496 | 0,58% | Hisse senetleri |
| ADAR1 Capital Management, LLC | $111.726.513 | 3.157.008 | 0,53% | Hisse senetleri |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $105.749.602 | 2.988.121 | 0,50% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $105.203.924 | 2.972.702 | 0,50% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $102.649.863 | 2.900.533 | 0,49% | Hisse senetleri |
| MAVERICK CAPITAL LTD | $100.119.159 | 2.829.024 | 0,47% | Hisse senetleri |
| Bank of New York Mellon Corp | $98.747.526 | 2.790.266 | 0,47% | Hisse senetleri |
| NATIONAL BANK OF CANADA /FI/ | $98.168.095 | 2.773.874 | 0,46% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $95.123.719 | 2.687.870 | 0,45% | Hisse senetleri |
| Weiss Asset Management LP | $89.984.454 | 2.542.652 | 0,43% | Hisse senetleri |
| Woodline Partners LP | $88.498.817 | 2.500.673 | 0,42% | Hisse senetleri |
| JANUS HENDERSON GROUP PLC | $85.790.341 | 3.095.448 | 0,41% | Hisse senetleri |
| CITIGROUP INC | $78.749.474 | 2.225.190 | 0,37% | Hisse senetleri |
| DME Capital Management, LP | $76.182.956 | 2.152.669 | 0,36% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $73.368.318 | 2.073.137 | 0,35% | Hisse senetleri |
Aktivistler ve %5+ sahipler 1 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Roivant Sciences Ltd. ×18 başvurular | 28 Şubat 2020 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 16 içeriden öğrenenler · 7 yöneticiler · 9 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Eric Venker | President & Immunovant CEO | 30 Eylül 2026 M | 1.599.154 | 0 | 23 | $-97.091.061 |
| Matthew Gline | CEO | 30 Eylül 2026 F | 16.583.774 | 0 | 4 | $-46.173.010 |
| Richard Pulik | CFO | 20 Eylül 2026 F | 269.681 | 0 | 2 | $-9.122.307 |
| Mayukh Sukhatme | President & CIO | 30 Eylül 2026 F | 18.583.860 | 0 | 13 | $-109.133.247 |
| Frank Torti | President and Vant Chair | 30 Eylül 2026 F | 13.495.893 | 0 | 3 | $-82.039.461 |
| Jennifer Humes | Chief Accounting Officer | 20 Eylül 2026 F | 106.419 | 0 | 1 | $-384.073 |
| Rakhi Kumar | Chief Accounting Officer | 20 Şubat 2025 F | 162.306 | 0 | 0 | $0 |
| Daniel Allen Gold | Yönetim kurulu üyesi | 16 Eylül 2026 A | 8.965.815 | 0 | 19 | $-147.382.307 |
| Melissa B, Epperly | Yönetim kurulu üyesi | 16 Eylül 2026 A | 14.954 | 0 | 5 | $-2.007.055 |
| Ilan Oren | Yönetim kurulu üyesi | 16 Eylül 2026 A | 123.680 | 0 | 0 | $0 |
| Meghan Fitzgerald | Yönetim kurulu üyesi | 16 Eylül 2026 A | 41.162 | 0 | 5 | $-3.271.652 |
| Keith S Manchester | Yönetim kurulu üyesi | 16 Eylül 2026 A | 1.753.457 | 0 | 20 | $-154.472.307 |
| James C Momtazee | Yönetim kurulu üyesi | 16 Eylül 2026 A | 111.959 | 0 | 0 | $0 |
| Andrew Lo | Yönetim kurulu üyesi | 15 Eylül 2022 A | 52.142 | 0 | 0 | $0 |
| Vivek Ramaswamy | 10% sahip | 15 Aralık 2025 M | 33.653.755 | 0 | 6 | $-105.881.464 |
| QVT Financial LP | · | 30 Haziran 2026 S | 13.689.166 | 0 | 19 | $-147.382.307 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 65 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| PTH · Invesco Exchange-Traded Fund Trust | 5,09% | 511.087 SH | 01 Ekim 2026 | Günlük |
| XMMO · Invesco Exchange-Traded Fund Trust | 3,61% | 6.900.746 SH | 01 Ekim 2026 | Günlük |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 1,73% | 51.097 SH | 01 Ekim 2026 | Günlük |
| IBB · iShares Trust | 1,56% | 3.945.976 SH | 11 Eylül 2026 | Günlük |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 1,33% | 426.543 SH | 01 Ekim 2026 | Günlük |
| PDP · Invesco Exchange-Traded Fund Trust | 0,83% | 333.906 SH | 01 Ekim 2026 | Günlük |
| LABU · Direxion Shares ETF Trust | 0,81% | 118.777 NS | 31 Temmuz 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,49% | 6.668.252 SH | 19 Ağustos 2026 | Günlük |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,48% | 258.044 SH | 19 Ağustos 2026 | Günlük |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,45% | 49.743 SH | 01 Ekim 2026 | Günlük |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,44% | 728.407 SH | 19 Ağustos 2026 | Günlük |
| IVOV · VANGUARD ADMIRAL FUNDS | 0,38% | 162.589 SH | 19 Ağustos 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,34% | 247.761 SH | 01 Ekim 2026 | Günlük |
| MIDU · Direxion Shares ETF Trust | 0,33% | 6.622 NS | 31 Temmuz 2026 | N-PORT |
| IYH · iShares Trust | 0,32% | 286.604 SH | 11 Eylül 2026 | Günlük |
| VFMO · VANGUARD WELLINGTON FUND | 0,32% | 182.053 SH | 19 Ağustos 2026 | Günlük |
| SMMD · iShares Trust | 0,28% | 260.561 SH | 11 Eylül 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,24% | 1.398.015 SH | 19 Ağustos 2026 | Günlük |
| SIZE · iShares Trust | 0,23% | 23.759 SH | 11 Eylül 2026 | Günlük |
| EUSA · iShares, Inc. | 0,22% | 104.334 SH | 11 Eylül 2026 | Günlük |
| VB · VANGUARD INDEX FUNDS | 0,21% | 11.546.599 SH | 19 Ağustos 2026 | Günlük |
| MTUM · iShares Trust | 0,20% | 1.176.567 SH | 11 Eylül 2026 | Günlük |
| IWS · iShares Trust | 0,20% | 730.954 SH | 11 Eylül 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,18% | 5.172.729 SH | 19 Ağustos 2026 | Günlük |
| IMCV · iShares Trust | 0,17% | 49.279 SH | 11 Eylül 2026 | Günlük |
| IWR · iShares Trust | 0,15% | 2.002.105 SH | 11 Eylül 2026 | Günlük |
| IMCB · iShares Trust | 0,14% | 58.450 SH | 11 Eylül 2026 | Günlük |
| IMCG · iShares Trust | 0,11% | 108.573 SH | 11 Eylül 2026 | Günlük |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 18.431 SH | 01 Ekim 2026 | Günlük |
| DFAC · Dimensional ETF Trust | 0,08% | 1.165.423 NS | 31 Temmuz 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,07% | 71.845 NS | 31 Temmuz 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,06% | 275.495 NS | 31 Temmuz 2026 | N-PORT |
| IWD · iShares Trust | 0,05% | 1.084.522 SH | 11 Eylül 2026 | Günlük |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,05% | 295.213 SH | 19 Ağustos 2026 | Günlük |
| DFAU · Dimensional ETF Trust | 0,04% | 153.970 NS | 31 Temmuz 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,04% | 24.056 NS | 31 Temmuz 2026 | N-PORT |
| ILCV · iShares Trust | 0,04% | 11.683 SH | 11 Eylül 2026 | Günlük |
| DFLV · Dimensional ETF Trust | 0,03% | 62.507 NS | 31 Temmuz 2026 | N-PORT |
| ILCB · iShares Trust | 0,03% | 9.666 SH | 11 Eylül 2026 | Günlük |
| ESGV · VANGUARD WORLD FUND | 0,03% | 110.742 SH | 19 Ağustos 2026 | Günlük |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,03% | 90.086 SH | 01 Ekim 2026 | Günlük |
| IWB · iShares Trust | 0,03% | 337.727 SH | 11 Eylül 2026 | Günlük |
| IUSG · iShares Trust | 0,03% | 227.241 SH | 11 Eylül 2026 | Günlük |
| IWV · iShares Trust | 0,03% | 134.424 SH | 11 Eylül 2026 | Günlük |
| VOTE · TCW ETF Trust | 0,03% | 8.439 NS | 31 Temmuz 2026 | N-PORT |
| ITOT · iShares Trust | 0,03% | 598.477 SH | 11 Eylül 2026 | Günlük |
| IYY · iShares Trust | 0,03% | 18.633 SH | 11 Eylül 2026 | Günlük |
| ILCG · iShares Trust | 0,03% | 19.200 SH | 11 Eylül 2026 | Günlük |
| IUSV · iShares Trust | 0,03% | 168.980 SH | 11 Eylül 2026 | Günlük |
| TOK · iShares Trust | 0,03% | 1.450 SH | 11 Eylül 2026 | Günlük |
| URTH · iShares, Inc. | 0,02% | 46.946 SH | 11 Eylül 2026 | Günlük |
| DFUS · Dimensional ETF Trust | 0,02% | 143.748 NS | 31 Temmuz 2026 | N-PORT |
| ACWI · iShares Trust | 0,02% | 165.388 SH | 11 Eylül 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,02% | 15.990.718 SH | 19 Ağustos 2026 | Günlük |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,02% | 80.578 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,02% | 41.202 SH | 19 Ağustos 2026 | Günlük |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 405.619 SH | 19 Ağustos 2026 | Günlük |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,01% | 8.472 SH | 01 Ekim 2026 | Günlük |
| DXUV · Dimensional ETF Trust | 0,01% | 927 NS | 31 Temmuz 2026 | N-PORT |
| RWK · Invesco Exchange-Traded Fund Trust … | 0,00% | 150 SH | 23 Eylül 2026 | Günlük |
| IJH · iShares Trust | · | 15.821.557 SH | 11 Eylül 2026 | Günlük |
| IJK · iShares Trust | · | 1.516.631 SH | 11 Eylül 2026 | Günlük |
| IJJ · iShares Trust | · | 965.622 SH | 21 Ağustos 2026 | Günlük |
| XJH · iShares Trust | · | 61.595 SH | 08 Eylül 2026 | Günlük |
| SMLF · iShares Trust | · | 75.677 SH | 11 Eylül 2026 | Günlük |
ROIV Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 19 analist
AL
Medyan hedef
$46.50
+30,2%
8 42,1%
Güçlü Al
9 47,4%
Al
2 10,5%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
12 analist · 2026-10-03Ortalama hedef $48.08 +34,6%
← Tüm hedeflerin altında
Mevcut fiyat $35.72
Düşük$41.00
Ortalama$48.08
Yüksek$55.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 6, 2026